Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.

Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ; Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators..

Eur Heart J. 2012 Feb;33(3):314-24. doi: 10.1093/eurheartj/ehr433.

3.

The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics.

Lowrie R, Mair FS, Greenlaw N, Forsyth P, McConnachie A, Richardson J, Khan N, Morrison D, Messow CM, Rae B, McMurray JJ.

Eur J Heart Fail. 2011 Aug;13(8):917-24. doi: 10.1093/eurjhf/hfr083.

5.

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators..

Am J Cardiovasc Drugs. 2007;7(5):373-80.

PMID:
18041162
9.

Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC.

Ann Intern Med. 2007 May 15;146(10):714-25.

PMID:
17502632
12.

Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.

Hamada M, Hara Y, Ohtsuka T, Suzuki J, Saeki H, Ogimoto A, Shigematsu Y.

J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S5-10.

PMID:
12688389
13.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
14.

Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?

Ho SF, O'Mahony MS, Steward JA, Burr ML, Buchalter M.

Age Ageing. 2004 Sep;33(5):488-92.

PMID:
15271642
15.
18.
19.
20.

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.

Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B, Heidenreich PA, Knabel T, Konstam MA, Steimle A, Warner Stevenson L.

J Am Coll Cardiol. 2003 May 7;41(9):1529-38.

Items per page

Supplemental Content

Support Center